Tech Company Financing Transactions

Eikonoklastes Therapeutics Funding Round

Eikonoklastes Therapeutics secured a Series A financing round on 6/30/2021. Investors included CincyTech, Elk Capital Ventures and JobsOhio.

Transaction Overview

Announced On
6/30/2021
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to conduct Investigational New Drug (IND) enabling studies for Eikonoklastes Therapeutics' L-ICON3 immune conjugate platform.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
981 Hill St.
Cincinnati, OH 45202
USA
Email Address
Overview
Eikonoklastes Therapeutics is advancing a new generation of tissue factor (TF) immunotherapies for the treatment of triple-negative breast cancer and other cancers and diseases with high morbidity and unmet clinical needs. Eikonoklastes' proprietary molecules are engineered for maximum efficacy and a superior safety profile.
Profile
Eikonoklastes Therapeutics LinkedIn Company Profile
Social Media
Eikonoklastes Therapeutics Company Twitter Account
Company News
Eikonoklastes Therapeutics News
Facebook
Eikonoklastes Therapeutics on Facebook
YouTube
Eikonoklastes Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Bruce Halpryn
  Bruce Halpryn LinkedIn Profile  Bruce Halpryn Twitter Account  Bruce Halpryn News  Bruce Halpryn on Facebook
Chief Medical Officer
Mark Dato
  Mark Dato LinkedIn Profile  Mark Dato Twitter Account  Mark Dato News  Mark Dato on Facebook
Co-Founder
Zhiwei Hu
  Zhiwei Hu LinkedIn Profile  Zhiwei Hu Twitter Account  Zhiwei Hu News  Zhiwei Hu on Facebook
VP - Bus. Development
Sam Lee
  Sam Lee LinkedIn Profile  Sam Lee Twitter Account  Sam Lee News  Sam Lee on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2021: Disco Technology venture capital transaction
Next: 6/30/2021: Skyfish venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary